GlaxoSmithKline Pharmaceuticals Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting

GlaxoSmithKline Pharma's board approved Q2/H1 consolidated financial results. Revenue for the half-year stood at Rs 1785.11 Cr, with profit at Rs 462.50 Cr. They also approved a Rs 1.74 Cr investment in a solar power project for their Nashik plant, aiming to boost green energy.